Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx DRUG PRICES AT PRODUCER LEVEL GROW 3% IN FIRST QUARTER

Executive Summary

Rx DRUG PRICES AT PRODUCER LEVEL GROW 3% IN FIRST QUARTER based on data from the Bureau of Labor Statistics' Producer Price Index. The first quarter increase indicates a moderating trend from 1987 when the first quarter producer price index for prescription drugs increased 4%. Although the December through March producer price figures are still preliminary, the 3% price increase is the smallest first quarter producer price run-up for prescription drugs in the 1980s, according to Bureau of Labor Statistics' data. With drug prices generally increasing 9-11% annually through the 1980s, first quarter producer prices for prescription drugs have historically risen 4% to 4.5%. The exception was 1984, when Rx drug prices at the producer level grew 3.7%. Drug categories showing the biggest first quarter price gains, according to the Bureau of Labor Statistics, were hormones (up 14.4%), CNS stimulants (up 8.7%), Rx cough/cold preparations (up 7.5%), vasodilators (up 6.6%), adult Rx multivitamins (up 6.4%), and Rx analgesics (up 5.3%). Despite showing the biggest price gain during the first quarter, price increases for hormones have not been steady, according to the Bureau of Labor Statistics. If the producer price index for hormones is considered for the four month period from November to March, prices rose only 1.3% Diuretic and anti-arthritic price declines during the first quarter indicated little pricing flexibility in these markets. The Bureau of Labor Statistics' figures show anti-arthritic prices at the manufacturer level falling .7% while diuretic prices edged down .6%.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS013580

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel